CD303 (BDCA-2) Antibody, anti-human, Vio® Bright FITC, REAfinity™ 130-113-656 from Miltenyi Biotec

Product Specs
ItemCD303 (BDCA-2) Antibody, anti-human, Vio® Bright FITC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-113-656
Quantity100 tests in 200 µL
ApplicationsFlow cytometry
Conjugate/TagVio Bright FITC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman, non-human primate
IsotypeIgG1
CloneREA693
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
Clonalitymonoclonal
Concentration1:50
ModificationsRecombinantly engineered
NCBI Full Gene NameC-type lectin domain family 4 member C
NCBI Gene AliasesBDCA-2, BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL, PRO34150
TargetCD303 (BDCA-2)
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36PloS oneJanuary 1, 2014Krupna-Gaylord MA, Liveris D, Love AC, Wormser GP, Schwartz I, Petzke MM.

(2) The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitisArthritis research & therapyOctober 24, 2013Zhang Y, Shi W, Tang S, Li J, Yin S, Gao X, Wang L, Zou L, Zhao J, Huang Y, et al.

(3) Plasmacytoid dendritic cells and CD8 T cells from pregnant women show altered phenotype and function following H1N1/09 infectionThe Journal of infectious diseasesOctober 1, 2013Vanders RL, Gibson PG, Murphy VE, Wark PA.

(4) Pivotal role of M-DC8⁺ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial productsBloodSeptember 13, 2012Dutertre CA, Amraoui S, DeRosa A, Jourdain JP, Vimeux L, Goguet M, Degrelle S, Feuillet V, Liovat AS, Müller-Trutwin M, et al.

(5) Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian speciesJournal of immunology (Baltimore, Md. : 1950)September 15, 2010Contreras V, Urien C, Guiton R, Alexandre Y, Vu Manh TP, Andrieu T, Crozat K, Jouneau L, Bertho N, Epardaud M, et al.

(6) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha productionThe Journal of experimental medicineJuly 4, 2005Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M.

(7) Expression of C-type lectin receptors by subsets of dendritic cells in human skinInternational immunologyJune 1, 2004Ebner S, Ehammer Z, Holzmann S, Schwingshackl P, Forstner M, Stoitzner P, Huemer GM, Fritsch P, Romani N.

(8) Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newbornsBloodFebruary 1, 2004De Wit D, Olislagers V, Goriely S, Vermeulen F, Wagner H, Goldman M, Willems F.

(9) Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host diseaseTransplantationJanuary 27, 2003Clark FJ, Freeman L, Dzionek A, Schmitz J, McMullan D, Simpson P, Mason J, Mahendra P, Craddock C, Griffiths M, et al.

(10) Plasmacytoid dendritic cells: from specific surface markers to specific cellular functionsHuman immunologyDecember 1, 2002Dzionek A, Inagaki Y, Okawa K, Nagafune J, Röck J, Sohma Y, Winkels G, Zysk M, Yamaguchi Y, Schmitz J.

(11) Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseasesThe Journal of investigative dermatologyNovember 1, 2002Wollenberg A, Wagner M, Günther S, Towarowski A, Tuma E, Moderer M, Rothenfusser S, Wetzel S, Endres S, Hartmann G.

(12) A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine patternJournal of immunology (Baltimore, Md. : 1950)June 15, 2002Ebner S, Hofer S, Nguyen VA, Fürhapter C, Herold M, Fritsch P, Heufler C, Romani N.

(13) Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantationBone marrow transplantationJune 1, 2002Arpinati M, Chirumbolo G, Urbini B, Martelli V, Stanzani M, Falcioni S, Bonifazi F, Bandini G, Tura S, Baccarani M, et al.

(14) Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individualsJournal of immunology (Baltimore, Md. : 1950)May 1, 2002Chehimi J, Campbell DE, Azzoni L, Bacheller D, Papasavvas E, Jerandi G, Mounzer K, Kostman J, Trinchieri G, Montaner LJ.

(15) BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta inductionThe Journal of experimental medicineDecember 17, 2001Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Günther G, Johnston I, Lanzavecchia A, Nagasaka T, et al.

(16) A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupusThe Journal of experimental medicineDecember 17, 2001Rönnblom L, Alm GV.

(17) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral bloodJournal of immunology (Baltimore, Md. : 1950)December 1, 2000Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J.

(18) Dendritic cells: multi-lineal and multi-functionalImmunology todaySeptember 1, 2000Grabbe S, Kämpgen E, Schuler G.

Be the First to Write a Review!

CD303 (BDCA-2) Antibody, anti-human, Vio® Bright FITC, REAfinity™ from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (18)

Reviews

CD303 (BDCA-2) Antibody, anti-human, Vio® Bright FITC, REAfinity™ from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map